National Health Investors, Inc. (NHI)
NYSE: NHI · Real-Time Price · USD
62.95
-1.60 (-2.48%)
Nov 13, 2026, 4:00 PM EST - Market closed
National Health Investors Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Rental Revenue | 275.48 | 271.6 | 257.05 | 249.23 | 217.7 | 271.05 |
Other Revenue | 163.97 | 83.88 | 55.29 | 49.72 | 36.37 | -1.55 |
| 459.42 | 379.29 | 335.58 | 320.39 | 278.76 | 297.17 | |
Revenue Growth (YoY | 29.21% | 13.03% | 4.74% | 14.93% | -6.19% | -9.86% |
Property Expenses | 132.41 | 71.91 | 53.42 | 51.1 | 37.98 | 11.64 |
Selling, General & Administrative | 34.09 | 29.53 | 21.79 | 19.82 | 25.32 | 19.34 |
Depreciation & Amortization | 96.66 | 80.94 | 71.44 | 69.97 | 70.88 | 80.8 |
Other Operating Expenses | 1 | 1.08 | 0.04 | 0.45 | 0.84 | 0.79 |
Total Operating Expenses | 264.15 | 183.47 | 146.69 | 141.34 | 135.03 | 112.56 |
Operating Income | 195.27 | 195.82 | 188.9 | 179.05 | 143.74 | 184.61 |
Interest Expense | -57.64 | -57.37 | -59.9 | -58.16 | -44.92 | -50.81 |
Other Non-Operating Income | 2.98 | -1.57 | - | 0.2 | 1.11 | 0.35 |
EBT Excluding Unusual Items | 139.28 | 136.88 | 129 | 121.09 | 99.93 | 134.15 |
Gain (Loss) on Sale of Investments | - | - | 6.26 | - | - | - |
Gain (Loss) on Sale of Assets | 567.4 | 0.46 | 6.68 | 14.72 | 28.34 | 32.5 |
Asset Writedown | -9.87 | - | -0.65 | -1.64 | -51.56 | -51.82 |
Other Unusual Items | 0.32 | 3.45 | -4.64 | 0.21 | -11.22 | -2.86 |
Pretax Income | 697.14 | 140.79 | 136.64 | 134.38 | 65.5 | 111.97 |
Income Tax Expense | 1.01 | - | - | - | - | - |
Earnings From Continuing Operations | 696.13 | 140.79 | 136.64 | 134.38 | 65.5 | 111.97 |
Minority Interest in Earnings | 1.34 | 1.39 | 1.35 | 1.27 | 0.9 | -0.16 |
Net Income | 697.46 | 142.18 | 137.99 | 135.65 | 66.4 | 111.8 |
Preferred Dividends & Other Adjustments | 1.07 | 0.2 | 0.12 | 0.06 | - | - |
Net Income to Common | 696.39 | 141.98 | 137.87 | 135.6 | 66.4 | 111.8 |
Net Income Growth | 373.49% | 2.98% | 1.67% | 104.20% | -40.61% | -39.61% |
Basic Shares Outstanding | 48 | 47 | 44 | 43 | 45 | 46 |
Diluted Shares Outstanding | 48 | 47 | 44 | 43 | 45 | 46 |
Shares Change | 4.42% | 6.69% | 1.64% | -3.14% | -2.04% | 2.31% |
EPS (Basic) | 14.40 | 3.03 | 3.14 | 3.13 | 1.48 | 2.45 |
EPS (Diluted) | 14.37 | 3.02 | 3.13 | 3.13 | 1.48 | 2.44 |
EPS Growth | 353.40% | -3.51% | 0.15% | 111.16% | -39.34% | -41.06% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share | 3.700 | 3.640 | 3.600 | 3.600 | 3.600 | 3.803 |
Dividend Growth | 2.21% | 1.11% | 0% | 0% | -5.33% | -13.78% |
Operating Margin | 42.50% | 51.63% | 56.29% | 55.88% | 51.56% | 62.12% |
Profit Margin | 151.58% | 37.43% | 41.08% | 42.32% | 23.82% | 37.62% |
EBITDA | 291.93 | 276.77 | 260.34 | 249.02 | 214.62 | 265.41 |
EBITDA Margin | 63.54% | 72.97% | 77.58% | 77.72% | 76.99% | 89.31% |
D&A For Ebitda | 96.66 | 80.94 | 71.44 | 69.97 | 70.88 | 80.8 |
EBIT | 195.27 | 195.82 | 188.9 | 179.05 | 143.74 | 184.61 |
EBIT Margin | 42.50% | 51.63% | 56.29% | 55.88% | 51.56% | 62.12% |
Funds From Operations (FFO) | 231.03 | 218.66 | 200.65 | 190.37 | 158.96 | 211.08 |
FFO Per Share | 4.76 | 4.65 | 4.55 | 4.39 | 3.55 | 4.62 |
Adjusted Funds From Operations (AFFO) | - | 218.66 | 200.65 | 190.37 | 158.96 | 211.08 |
AFFO Per Share | - | 4.65 | 4.55 | 4.39 | 3.55 | 4.62 |
FFO Payout Ratio | 77.06% | 77.61% | 78.00% | 82.07% | 101.77% | 86.65% |
Effective Tax Rate | 0.14% | - | - | - | - | - |
Revenue as Reported | 455.76 | 375.63 | 335.18 | 319.84 | 278.19 | 298.72 |